Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Therapy-Related Toxicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01015326
What this trial is testing

Development of Dermatology-related Quality of Life Assessment in Patients Treated With Epidermal Growth Factor Receptor (EGFR) Inhibitors

Who this might be right for
Skin Toxicities
Northwestern University 32
Not applicableStudy completedNCT06558084
What this trial is testing

Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine Therapy

Who this might be right for
Toxicity, DrugProgression, Disease
Ain Shams University 64
Not applicableStudy completedNCT06817044
What this trial is testing

Optimising Screening for the Cardiotoxic Effects of Cancer Therapy

Who this might be right for
Ventricular DysfunctionCardiotoxicityChemotherapeutic Toxicity
Barts & The London NHS Trust 80
Post-approval studies (Phase 4)Looking for participantsNCT06183437
What this trial is testing

The STOP-MED CTRCD Trial

Who this might be right for
Heart FailureCardiotoxicityCardiac Toxicity+2 more
Dinesh Thavendiranathan 335
Not applicableLooking for participantsNCT04797143
What this trial is testing

Impact of a Multidisciplinary Consultation Program on Drug Adherence in First Oral Anticancer Treatment

Who this might be right for
Multidisciplinary Consultation ProgramAdherence to Oral Anticancer TreatmentDrug Related Toxicity+1 more
Centre Hospitalier Universitaire, Amiens 300
Large-scale testing (Phase 3)Study completedNCT00400946
What this trial is testing

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemia
Dana-Farber Cancer Institute 800
Large-scale testing (Phase 3)Ended earlyNCT05128773
What this trial is testing

Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity

Who this might be right for
Breast Cancer
Sanofi 3
Post-approval studies (Phase 4)Not Yet RecruitingNCT07254221
What this trial is testing

Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients

Who this might be right for
Anthracycline-induced Cardiac ToxicityBreast CancerAnthracycline Related Cardiotoxicity in Breast Cancer+1 more
Shiraz University of Medical Sciences 400
Not applicableLooking for participantsNCT05512169
What this trial is testing

Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia

Who this might be right for
ALL, ChildhoodPediatric CancerToxicity, Drug+5 more
University of Geneva, Switzerland 556
Not applicableNot Yet RecruitingNCT07008027
What this trial is testing

Real World Asparaginase Therapy Toxicity

Who this might be right for
Drug Toxicity
St. Jude Children's Research Hospital 200
Testing effectiveness (Phase 2)Study completedNCT00520702
What this trial is testing

3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 168
Large-scale testing (Phase 3)Study completedNCT01696500
What this trial is testing

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal Necrolysis
Nihon Pharmaceutical Co., Ltd 10
Testing effectiveness (Phase 2)Ended earlyNCT06045793
What this trial is testing

Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST)

Who this might be right for
Cocaine UseCocaine IntoxicationCocaine Toxicity+2 more
Tonix Pharmaceuticals, Inc. 3
Not applicableStudy completedNCT06778122
What this trial is testing

In-Bedroom Renewed Air as Anti-inflammatory Adjuvant Therapy in Cancer Survivors

Who this might be right for
Cancer SurvivorsCardiotoxicityCardiovascular Toxicity Induced by Antitumoral Drugs
University College, London 10
Testing effectiveness (Phase 2)Study completedNCT00028964
What this trial is testing

Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/Organ
University of California, San Francisco
Not applicableStudy completedNCT03882541
What this trial is testing

Could Music be an Alternative to Sedation in Patients Treated Total Knee Arthroplasty With Regional Anesthesia?

Who this might be right for
AnxietySurgeryDrug Toxicity+2 more
Consorci Sanitari de l'Anoia 85
Very early researchLooking for participantsNCT06119490
What this trial is testing

Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis

Who this might be right for
Toxic Epidermal Necrolysis
Peng Zhang 30
Not applicableStudy completedNCT07272538
What this trial is testing

Predicting Chemotherapy Toxicity Using FRAIL and FIND in Older Adults With Gastrointestinal Cancers

Who this might be right for
Gastrointestinal CancersFrailty at Older AdultsChemotherapy
Ankara Etlik City Hospital 84
Not applicableStudy completedNCT00875238
What this trial is testing

Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab

Who this might be right for
Breast CancerCardiac ToxicityCardiovascular Complications
Vanderbilt University 133
Large-scale testing (Phase 3)Ended earlyNCT00016276
What this trial is testing

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Who this might be right for
Cardiac ToxicityInflammatory Breast CancerStage IIIA Breast Cancer+2 more
National Cancer Institute (NCI) 396
Next Page